Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
about
Cancer chemoprevention with dietary isothiocyanates mature for clinical translational researchTumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected]Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging.Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.Atomic force microscopy characterization of kinase-mediated phosphorylation of a peptide monolayer.High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.HDGF: a novel jack-of-all-trades in cancer.Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion.Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.The effect of benzyl isothiocyanate and its computer-aided design derivants targeting alkylglycerone phosphate synthase on the inhibition of human glioma U87MG cell line.Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma.Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis.The expression and clinical significance of HDGF in osteosarcoma.Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families.Integrating proteomics with electrochemistry for identifying kinase biomarkers.Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells.The evaluation of hepatoma-derived growth factor in determining of prognosis and estimating of invasive probability of tumoral cells, recurrent, and metastasis of lymphatic glands in breast carcinoma.
P2860
Q28269727-C90A565F-2CFD-4056-A15D-7EFBE6670020Q33613560-42205639-B261-4DCB-A306-47D0F9103F4AQ34639683-43F4EF01-26F8-455A-8017-D3147DFD21A7Q35159916-A43CA749-0E7A-4CFB-819B-35954DD8F780Q35777081-8FE20284-26E7-48EC-8DDC-7A14C0455331Q36140779-4C86C857-6B8F-49F3-8CF2-7F9EA3DEB248Q36191446-6AAEF178-76ED-41FF-8779-15011ADDCC78Q37627214-2C52E095-E380-4F58-890A-20001A8BF152Q38252480-7CF1F6D7-BE79-4BC5-8287-7C55B85F56B5Q38316102-0238F083-60F1-49E6-A50E-8FB1D9031A66Q38765991-E844D1CD-3009-4230-BD89-8EEA4F4DB8CAQ38925261-B198B6F7-F61C-4E99-8D90-D658AD53FE7EQ38952715-69BFDFAD-5C3D-4EE8-9DC3-E7A9F7A40044Q38978907-B9491942-3675-4973-A6F5-8979062348D0Q39038597-22C020A7-A767-4228-91D9-049FDD4768D8Q39121566-FBEF75E4-4C80-413B-B2F7-C8CFDA53CABBQ40622697-F2DAB023-BFA7-4E14-8B78-E60C6BFFFBF1Q40736209-5491A0F5-1EAD-4C06-B6B0-C469E30BAFC0Q41206460-CAB6A49F-5293-438A-AD10-695C7C0AC284Q43246559-FE8DE0AC-8650-4D89-84FB-DB0A7144DF92Q45784223-83B52A59-9B94-49A2-882E-9862FE99BF99Q47165042-DBDB7FF0-68DD-4AB1-AE15-8214EF535B54Q47210101-89E803C0-3CFC-4C89-9523-63227C2D03D0Q47405466-9C9DC698-65F6-489A-9ABB-13D6C3342DC8Q55263017-BA737775-A9D6-48FA-A3C7-EA639C7EDE5A
P2860
Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hepatoma-derived growth factor ...... elial--mesenchymal transition.
@en
Hepatoma-derived growth factor ...... elial--mesenchymal transition.
@nl
type
label
Hepatoma-derived growth factor ...... elial--mesenchymal transition.
@en
Hepatoma-derived growth factor ...... elial--mesenchymal transition.
@nl
prefLabel
Hepatoma-derived growth factor ...... elial--mesenchymal transition.
@en
Hepatoma-derived growth factor ...... elial--mesenchymal transition.
@nl
P2093
P2860
P356
P1476
Hepatoma-derived growth factor ...... elial--mesenchymal transition.
@en
P2093
Han-En Tsai
Hsiao-Mei Kuo
Hsuan-Yu Chen
Jian-Ching Wu
Jong-Kang Liu
Mei-Lang Kung
Ming-Hong Tai
Ming-Hsin Yeh
San-Cher Chen
Tsung-Hui Hu
P2860
P304
P356
10.1002/PATH.3988
P577
2012-05-23T00:00:00Z